Cancer and HIV are inextricably linked. Although the advent of antiretroviral therapy has led
to a marked decline in the incidence of malignancies classically linked to …

HIV+ persons have a significantly increased risk of cancer when compared to the general
population. The excess cancer risk observed during HIV infection is particularly higher for …

The advent of highly active antiretroviral therapy (HAART) has significantly reduced the
incidence of AIDS events, including AIDS-defining malignancies. Nevertheless, several …

The epidemiology of cancer among HIV-infected people has evolved since the beginning of
the HIV epidemic with particularly marked changes since the introduction of modern …

Cancers associated with immunosuppression and infections have long been recognized as
a major complication of HIV/AIDS. More recently, persons living with HIV are increasingly …

Highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV)
infection has been widely available in industrialized countries since 1996; its widespread …

The field of HIV-associated cancer has undergone a number of changes and advances in
the past several years, and this book was conceived to fill the need for a resource that …

Cancer is increasingly recognized as a complication of HIV infection in both resource-rich
and resource-limited areas. The traditional AIDS-defining cancers, including Kaposi …

Non-AIDS-defining malignancies account for more morbidity and mortality than AIDS-
defining malignancies in the antiretroviral therapy era. Traditional risk factors play a …

Prevention and screening management procedures need to be assessed on the basis of
specific evidence-based studies in the HIV-infected population. Interventions, known to be …